MBC BioLabs Longevity Innovation Forum
Join us for our fifth Innovation Forum, where we'll highlight pioneering startups reimagining how we prevent and treat age-related disease. Together, we’re bringing the longevity community of founders, funders, and partners driving the future of healthspan. Presenting startups include:
Arda Therapeutics: Taking aim at chronic diseases by eliminating the pathogenic cells that drive them.
Permanence Bio: Protecting the genome.
Adjuvia Therapeutics: Harnessing the Power of Nature's Designs.
General Control Biotechnologies: Engineering epigenetic medicines for the complexity of age-related diseases.
Gordian Biotechnology: Discovering new therapies for complex age-related disease.
Deciduous Therapeutics: Developing a novel class of immune-modulatory therapies designed to promote healthy lifespan.
Matter Bio: Promoting longevity through DNA information preservation.
Cavalry: Engineering targeted growth factors.
Euler Biologics: Antibody-based drugs keeping older adults stronger for longer
Posters: Sculpta Bio, Rejoovenate Bio, NeuroAge Therapeutics, Cerepeut, Inapill, Aperture Therapeutics, Lento Bio, Reservoir Neuroscience, Inixi Bio, Cyclarity Therapeutics
This is an invitation-only event with a thoughtfully curated group of investors, business development teams, and longevity founders shaping the landscape. Expect meaningful dialogue, new connections, and startups presenting what’s next in the science of aging.
Agenda and more details to follow.